Biotron Limited (BIT.AX)

AUD 0.02

(-5.88%)

Revenue Summary of Biotron Limited

  • Biotron Limited's latest annual revenue in 2024 was - AUD , down -100.0% from previous year.
  • Biotron Limited's latest quarterly revenue in 2024 FY was - AUD , down -100.0% from previous quarter.
  • Biotron Limited reported a annual revenue of 1.43 Million AUD in annual revenue 2023, down -8.16% from previous year.
  • Biotron Limited reported a annual revenue of 1.55 Million AUD in annual revenue 2022, up 6.61% from previous year.
  • Biotron Limited reported a quarterly revenue of - AUD for 2024 FY, down -100.0% from previous quarter.
  • Biotron Limited reported a quarterly revenue of - AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Biotron Limited (2024 - 2000)

Historical Annual Revenue of Biotron Limited (2024 - 2000)

Year Revenue Revenue Growth
2024 - AUD -100.0%
2023 1.43 Million AUD -8.16%
2022 1.55 Million AUD 6.61%
2021 1.46 Million AUD 82.05%
2020 803.02 Thousand AUD -25.15%
2019 1.07 Million AUD -33.88%
2018 1.62 Million AUD -2.22%
2017 1.65 Million AUD 7.19%
2016 1.54 Million AUD -7.42%
2015 1.67 Million AUD -2.92%
2014 1.72 Million AUD 93.11%
2013 891.95 Thousand AUD 0.0%
2012 - AUD 0.0%
2011 - AUD 0.0%
2010 - AUD 0.0%
2009 - AUD 0.0%
2008 - AUD -100.0%
2007 402.45 Thousand AUD -49.37%
2006 794.86 Thousand AUD 0.0%
2005 - AUD 0.0%
2004 - AUD 0.0%
2003 - AUD -100.0%
2002 62.74 Thousand AUD 380.4%
2001 13.06 Thousand AUD 0.0%
2000 - AUD 0.0%

Peer Revenue Comparison of Biotron Limited

Name Revenue Revenue Difference
EZZ Life Science Holdings Limited 66.44 Million AUD 100.0%
Anatara Lifesciences Ltd - AUD NaN%
Zelira Therapeutics Limited 94.95 Thousand AUD 100.0%
Biome Australia Limited 13 Million AUD 100.0%
Patrys Limited 1.39 Million AUD 100.0%
Orthocell Limited 5.31 Million AUD 100.0%
Imugene Limited - AUD NaN%
Noxopharm Limited 2.4 Million AUD 100.0%
PYC Therapeutics Limited 22.05 Million AUD 100.0%
Chimeric Therapeutics Limited 7.45 Million AUD 100.0%
Prescient Therapeutics Limited 3.71 Million AUD 100.0%
Proteomics International Laboratories Limited 892.14 Thousand AUD 100.0%
Cynata Therapeutics Limited 2.31 Million AUD 100.0%
CSL Limited 22.41 Billion AUD 100.0%
Arovella Therapeutics Limited 17 Thousand AUD 100.0%
Bio-Gene Technology Limited 18.32 Thousand AUD 100.0%
Clinuvel Pharmaceuticals Limited 88.17 Million AUD 100.0%
Starpharma Holdings Limited 8.28 Million AUD 100.0%
Nanollose Limited 12.5 Thousand AUD 100.0%
Memphasys Limited 60 Thousand AUD 100.0%
Invex Therapeutics Ltd 1.21 Million AUD 100.0%
NeuroScientific Biopharmaceuticals Limited - AUD NaN%
Amplia Therapeutics Limited 4.45 Million AUD 100.0%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD 100.0%
Island Pharmaceuticals Limited 1.25 Million AUD 100.0%
Race Oncology Limited 4 Million AUD 100.0%
Nyrada Inc. - AUD NaN%
Telix Pharmaceuticals Limited 496.65 Million AUD 100.0%
Dimerix Limited 583.47 Thousand AUD 100.0%
PharmAust Limited - AUD NaN%
Immutep Limited 3.5 Million AUD 100.0%
Clarity Pharmaceuticals Ltd 11.5 Million AUD 100.0%
Alterity Therapeutics Limited 4.01 Million AUD 100.0%
BTC Health Limited 16.36 Thousand AUD 100.0%
Acrux Limited 5.09 Million AUD 100.0%
Neuren Pharmaceuticals Limited 231.92 Million AUD 100.0%
Tissue Repair Ltd 152.24 Thousand AUD 100.0%
AdAlta Limited 1.73 Million AUD 100.0%
Radiopharm Theranostics Limited 299.22 Thousand AUD 100.0%
Hexima Limited - AUD NaN%
AnteoTech Limited 460.39 Thousand AUD 100.0%
Paradigm Biopharmaceuticals Limited 65.8 Thousand AUD 100.0%
Recce Pharmaceuticals Ltd - AUD NaN%
Avecho Biotechnology Limited 473.55 Thousand AUD 100.0%
Actinogen Medical Limited 9.93 Million AUD 100.0%
Immuron Limited 4.9 Million AUD 100.0%
Argenica Therapeutics Limited 2.59 Million AUD 100.0%